I don't think the way the FDA has done this has been productive. The APC, which represents over 600 compounding pharmacies in the US, has sent a letter to the FDA urging it to use enforcement discretion and allow compounders an extended off-ramp to help transition patients
The approval rate on appeal is approximately 40% per Centene's 2025 disclosure
One in three Canadians are currently living with obesity, and in 10 years, that number is going to change to about 50 per cent, so this is really an opportunity for policymakers to take action. LISTEN | WHO conditionally recommends GLP-1 drugs for obesity: The WHOs first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines
What makes 5-Amino-1MQ especially promising is its ability to selectively target adipose (fat) tissue without affecting muscle tissue, making it an intriguing option for weight management and overall metabolic support
Martin utilizes Emsculpt NEO technology for muscle growth, tissue lifting, and fat eliminationtechniques favored by NFL athletes and celebrities for strength and longevity
This could indicate a systemic drug reaction